Intrinsically Disordered Proteins (IDPs) and Drug Discovery

Intrinsically Disordered Proteins (IDPs) and Drug Discovery

Intrinsically Disordered Proteins (IDPs) are an emerging family of proteins whose which characteristic feature is that they don’t present a folded structure, and thus challenge the sequence-structure-function paradigm. This lack of stable structure, over the...
Our Drug Discovery SaaS platform will be presented at the ICO

Our Drug Discovery SaaS platform will be presented at the ICO

Computational design can reduce 30% of time and costs of the development of a new cancer treatment. In fact, this is the principal strength that the Mind the Byte’s pay-per-use SaaS (Software as a Service) platform, which will be presented at the Catalan...
You can be part of our innovative project DataNimbus

You can be part of our innovative project DataNimbus

Last July, the European Commission granted Mind the Byte with a SME-Instrument Phase I project for the feasibility study of our innovative project DataNimbus. With DataNimbus we want to develop a platform to optimize omics data processing (including data upload,...